Evolus, Inc. ($EOLS)
Filing Information
| Accession Number | 0001570562-26-000045 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
47,604
Total Value
$146,629.45
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer and Head of Research & Development | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 8,804 | $0.00 | $0.00 | 460,538 | Direct | โ | View Details | |
Chief Medical Officer and Head of Research & Development | Common Stock | โ | Mar 17, 2026 | Sale | 29,996 | $4.89 | $146,629.45 | 430,542 | Direct | โ | View Details | |
Chief Medical Officer and Head of Research & Development | Performance Restricted Stock Units | Derivative | Mar 16, 2026 | Exercise/Conversion | 8,804 | $0.00 | $0.00 | 8,802 | Direct | โ | View Details |